TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2341459
log Bayes Factor = 0.0435257
Chromosome 2   position 44,768,202  (GRCh37) Explore rs2341459 on Ensembl!
Variant rs2341459 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
K80.5 Calculus of bile duct without cholangitis or cholecystitis
0.093 0.907 0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
0.083 0.917 0.000
K80 Cholelithiasis
0.043 0.957 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.040 0.960 0.000
K80.4 Calculus of bile duct with cholecystitis
0.038 0.962 0.000
T39.1 4-Aminophenol derivatives
0.038 0.962 0.000
H20.9 Iridocyclitis, unspecified
0.000 0.963 0.037
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.037 0.963 0.000
K80.2 Calculus of gallbladder without cholecystitis
0.037 0.963 0.000
T39.0 Salicylates
0.034 0.966 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.034 0.966 0.000
H20 Iridocyclitis
0.000 0.967 0.033
K80.0 Calculus of gallbladder with acute cholecystitis
0.033 0.967 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.031 0.969 0.000
K80.3 Calculus of bile duct with cholangitis
0.031 0.969 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.031 0.969 0.000
H20.8 Other iridocyclitis
0.000 0.970 0.030
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.029 0.971 0.000
H25.0 Senile incipient cataract
0.000 0.971 0.029
T39.4 Antirheumatics, not elsewhere classified
0.029 0.971 0.000
T39.2 Pyrazolone derivatives
0.029 0.971 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.028 0.971 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.028 0.972 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.028 0.972 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.027 0.973 0.000
T43.6 Psychostimulants with abuse potential
0.026 0.974 0.000
H20.0 Acute and subacute iridocyclitis
0.000 0.974 0.026
T40.2 Other opioids
0.026 0.974 0.000
T40.4 Other synthetic narcotics
0.026 0.974 0.000
T36 Poisoning by systemic antibiotics
0.025 0.975 0.000
H25 Senile cataract
0.000 0.976 0.024
H27 Other disorders of lens
0.000 0.976 0.024
T46 Poisoning by agents primarily affecting the cardiovascular system
0.024 0.976 0.000
H20.2 Lens-induced iridocyclitis
0.000 0.976 0.024
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.024 0.976 0.000
H25-H28 Disorders of lens
0.000 0.976 0.024
T40.6 Other and unspecified narcotics
0.024 0.976 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.023 0.976 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.023 0.976 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.023 0.977 0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body
0.000 0.977 0.023
H27.1 Dislocation of lens
0.000 0.977 0.023
T41 Poisoning by anaesthetics and therapeutic gases
0.023 0.977 0.000
H18.5 Hereditary corneal dystrophies
0.000 0.977 0.023
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction
0.022 0.977 0.000
H27.0 Aphakia
0.000 0.978 0.022
T43.8 Other psychotropic drugs, not elsewhere classified
0.022 0.978 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.022 0.978 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.022 0.978 0.000
H18 Other disorders of cornea
0.000 0.978 0.022
T36.0 Penicillins
0.022 0.978 0.000
H20.1 Chronic iridocyclitis
0.000 0.978 0.022
T43.9 Psychotropic drug, unspecified
0.021 0.979 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.021 0.979 0.000
T40.8 Lysergide [LSD]
0.021 0.979 0.000
T40.7 Cannabis (derivatives)
0.021 0.979 0.000
T40.0 Opium
0.021 0.979 0.000
K80.8 Other cholelithiasis
0.021 0.979 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.021 0.979 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.021 0.979 0.000
T40.1 Heroin
0.020 0.979 0.000
H18.4 Corneal degeneration
0.000 0.980 0.020
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.020 0.980 0.000
H25.9 Senile cataract, unspecified
0.000 0.980 0.020
T42.1 Iminostilbenes
0.020 0.980 0.000
C79 Secondary malignant neoplasm of other sites
0.019 0.981 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.019 0.981 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.019 0.981 0.000
T42.4 Benzodiazepines
0.019 0.981 0.000
T40.3 Methadone
0.019 0.981 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.019 0.981 0.000
T46.1 Calcium-channel blockers
0.019 0.981 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.018 0.981 0.000
T43.2 Other and unspecified antidepressants
0.019 0.981 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.018 0.981 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.018 0.982 0.000
H28 Cataract and other disorders of lens in diseases classified elsewhere
0.000 0.982 0.018
T40.5 Cocaine
0.018 0.982 0.000
T47.4 Other laxatives
0.018 0.982 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.018 0.982 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.018 0.982 0.000
H27.8 Other specified disorders of lens
0.000 0.982 0.018
T36.9 Systemic antibiotic, unspecified
0.018 0.982 0.000
T36.7 Antifungal antibiotics, systemically used
0.018 0.982 0.000
T36.6 Rifamycins
0.018 0.982 0.000
T36.5 Aminoglycosides
0.018 0.982 0.000
T36.2 Chloramphenicol group
0.018 0.982 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.018 0.982 0.000
T36.3 Macrolides
0.018 0.982 0.000
H25.8 Other senile cataract
0.000 0.982 0.018
H25.2 Senile cataract, morgagnian type
0.000 0.982 0.018
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.018 0.982 0.000
T36.4 Tetracyclines
0.018 0.982 0.000
T47.2 Stimulant laxatives
0.018 0.982 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.018 0.982 0.000
H27.9 Disorder of lens, unspecified
0.000 0.982 0.018
T46.8 Antivaricose drugs, including sclerosing agents
0.017 0.982 0.000
T46.7 Peripheral vasodilators
0.017 0.982 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.017 0.982 0.000
T42.2 Succinimides and oxazolidinediones
0.017 0.982 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.017 0.983 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.017 0.983 0.000
T37.5 Antiviral drugs
0.017 0.983 0.000
T37.4 Anthelminthics
0.017 0.983 0.000
T37.3 Other antiprotozoal drugs
0.017 0.983 0.000
T37.1 Antimycobacterial drugs
0.017 0.983 0.000
T37.0 Sulphonamides
0.017 0.983 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.017 0.983 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.017 0.983 0.000
T47.7 Emetics
0.017 0.983 0.000
T47.5 Digestants
0.017 0.983 0.000
T47.3 Saline and osmotic laxatives
0.017 0.983 0.000
T36.8 Other systemic antibiotics
0.017 0.983 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.017 0.983 0.000
T47.6 Antidiarrhoeal drugs
0.017 0.983 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.017 0.983 0.000
H15 Disorders of sclera
0.000 0.983 0.017
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.017 0.983 0.000
T48.4 Expectorants
0.017 0.983 0.000
T48.3 Antitussives
0.017 0.983 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.017 0.983 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.017 0.983 0.000
T48.0 Oxytocic drugs
0.017 0.983 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.017 0.983 0.000
T38.5 Other oestrogens and progestogens
0.017 0.983 0.000
M16.0 Primary coxarthrosis, bilateral
0.000 0.983 0.017
H22 Disorders of iris and ciliary body in diseases classified elsewhere
0.000 0.983 0.017
T41.5 Therapeutic gases
0.016 0.983 0.000
T41.4 Anaesthetic, unspecified
0.016 0.983 0.000
T41.3 Local anaesthetics
0.016 0.983 0.000
T41.2 Other and unspecified general anaesthetics
0.016 0.983 0.000
T41.1 Intravenous anaesthetics
0.016 0.983 0.000
T41.0 Inhaled anaesthetics
0.016 0.983 0.000
C79.2 Secondary malignant neoplasm of skin
0.017 0.983 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.017 0.983 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.016 0.984 0.000
H18.0 Corneal pigmentations and deposits
0.000 0.984 0.016
T48.5 Anti-common-cold drugs
0.016 0.984 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.016 0.984 0.000
T38.9 Other and unspecified hormone antagonists
0.016 0.984 0.000
T38.7 Androgens and anabolic congeners
0.016 0.984 0.000
T38.4 Oral contraceptives
0.016 0.984 0.000
T38.2 Antithyroid drugs
0.016 0.984 0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere
0.000 0.984 0.016
H18.7 Other corneal deformities
0.000 0.984 0.016
T37.2 Antimalarials and drugs acting on other blood protozoa
0.016 0.984 0.000
H52.1 Myopia
0.000 0.984 0.016
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.016 0.984 0.000
T38.1 Thyroid hormones and substitutes
0.016 0.984 0.000
Chapter VII Diseases of the eye and adnexa
0.000 0.984 0.016
H21 Other disorders of iris and ciliary body
0.000 0.985 0.015
T49.9 Topical agent, unspecified
0.015 0.985 0.000
T49.8 Other topical agents
0.015 0.985 0.000
T49.7 Dental drugs, topically applied
0.015 0.985 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.015 0.985 0.000
T49.5 Ophthalmological drugs and preparations
0.015 0.985 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.015 0.985 0.000
T49.3 Emollients, demulcents and protectants
0.015 0.985 0.000
T49.2 Local astringents and local detergents
0.015 0.985 0.000
T49.1 Antipruritics
0.015 0.985 0.000
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction
0.000 0.985 0.015
H18.8 Other specified disorders of cornea
0.000 0.985 0.015
T38.0 Glucocorticoids and synthetic analogues
0.015 0.985 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.015 0.985 0.000
H18.3 Changes in corneal membranes
0.000 0.985 0.015
T42.3 Barbiturates
0.015 0.985 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.015 0.985 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.014 0.985 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.014 0.985 0.000
H28.0 Diabetic cataract
0.000 0.985 0.014
T47.0 Histamine H(2)-receptor antagonists
0.014 0.985 0.000
H52 Disorders of refraction and accommodation
0.000 0.986 0.014
H26.4 After-cataract
0.000 0.986 0.014
H26 Other cataract
0.000 0.986 0.014
H17 Corneal scars and opacities
0.000 0.986 0.014
H50 Other strabismus
0.000 0.986 0.014
T42.0 Hydantoin derivatives
0.014 0.986 0.000
C79.6 Secondary malignant neoplasm of ovary
0.014 0.986 0.000
H50.5 Heterophoria
0.000 0.986 0.014
H18.2 Other corneal oedema
0.000 0.986 0.013
H18.6 Keratoconus
0.000 0.986 0.013
H28.8 Other disorders of lens in diseases classified elsewhere
0.000 0.987 0.013
H28.2 Cataract in other diseases classified elsewhere
0.000 0.987 0.013
H28.1 Cataract in other endocrine, nutritional and metabolic diseases
0.000 0.987 0.013
H18.9 Disorder of cornea, unspecified
0.000 0.987 0.013
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.013 0.987 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.013 0.987 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.013 0.987 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.013 0.987 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.013 0.987 0.000
T44.0 Anticholinesterase agents
0.013 0.987 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.013 0.987 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.013 0.987 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.013 0.987 0.000
H43-H45 Disorders of vitreous body and globe
0.000 0.987 0.013
H18.1 Bullous keratopathy
0.000 0.987 0.013
H15.0 Scleritis
0.000 0.987 0.013
H15.9 Disorder of sclera, unspecified
0.000 0.987 0.013
H15.1 Episcleritis
0.000 0.987 0.012
I63 Cerebral infarction
0.012 0.988 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.012 0.988 0.000
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere
0.000 0.988 0.012
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere
0.000 0.988 0.012
K80.1 Calculus of gallbladder with other cholecystitis
0.012 0.988 0.000
H21.9 Disorder of iris and ciliary body, unspecified
0.000 0.988 0.012
H50.1 Divergent concomitant strabismus
0.000 0.988 0.012
H21.1 Other vascular disorders of iris and ciliary body
0.000 0.988 0.012
H22.1 Iridocyclitis in other diseases classified elsewhere
0.000 0.988 0.012
H19.1 Herpesviral keratitis and keratoconjunctivitis
0.000 0.988 0.012
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
0.000 0.988 0.012
H21.4 Pupillary membranes
0.000 0.988 0.012
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere
0.000 0.988 0.012
H19.0 Scleritis and episcleritis in diseases classified elsewhere
0.000 0.988 0.012
H52.7 Disorder of refraction, unspecified
0.000 0.988 0.012
C79.9 Secondary malignant neoplasm, unspecified site
0.012 0.988 0.000
H46-H48 Disorders of optic nerve and visual pathways
0.000 0.988 0.012
H15.8 Other disorders of sclera
0.000 0.988 0.011
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.011 0.988 0.000
H21.3 Cyst of iris, ciliary body and anterior chamber
0.000 0.989 0.011
H30-H36 Disorders of choroid and retina
0.000 0.989 0.011
H21.5 Other adhesions and disruptions of iris and ciliary body
0.000 0.989 0.011
H16 Keratitis
0.000 0.989 0.011
T45.2 Vitamins, not elsewhere classified
0.011 0.989 0.000
H52.4 Presbyopia
0.000 0.989 0.011
H43.8 Other disorders of vitreous body
0.000 0.989 0.011
H50.4 Other and unspecified heterotropia
0.000 0.989 0.011
H21.8 Other specified disorders of iris and ciliary body
0.000 0.989 0.011
T45.9 Primarily systemic and haematological agent, unspecified
0.010 0.989 0.000
T45.8 Other primarily systemic and haematological agents
0.010 0.989 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.010 0.989 0.000
T45.6 Fibrinolysis-affecting drugs
0.010 0.989 0.000
T45.3 Enzymes, not elsewhere classified
0.010 0.989 0.000
H43 Disorders of vitreous body
0.000 0.989 0.011
H46 Optic neuritis
0.000 0.989 0.011
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere
0.000 0.989 0.010
T45.4 Iron and its compounds
0.010 0.989 0.000
H04.5 Stenosis and insufficiency of lachrymal passages
0.000 0.989 0.011
H52.6 Other disorders of refraction
0.000 0.989 0.010
H52.5 Disorders of accommodation
0.000 0.989 0.010
H50.2 Vertical strabismus
0.000 0.989 0.010
H26.1 Traumatic cataract
0.000 0.990 0.010
H21.0 Hyphaema
0.000 0.990 0.010
T45.1 Antineoplastic and immunosuppressive drugs
0.010 0.990 0.000
H51 Other disorders of binocular movement
0.000 0.990 0.010
H17.1 Other central corneal opacity
0.000 0.990 0.010
H17.0 Adherent leukoma
0.000 0.990 0.010
H44 Disorders of globe
0.000 0.990 0.010
H50.3 Intermittent heterotropia
0.000 0.990 0.010
M81.98 Osteoporosis, unspecified (Other)
0.010 0.990 0.000
H52.3 Anisometropia and aniseikonia
0.000 0.990 0.010
H26.3 Drug-induced cataract
0.000 0.990 0.010
H33.1 Retinoschisis and retinal cysts
0.000 0.990 0.010
H26.8 Other specified cataract
0.000 0.990 0.010
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.010 0.990 0.000
H04 Disorders of lachrymal system
0.000 0.990 0.010
H26.0 Infantile, juvenile and presenile cataract
0.000 0.990 0.009
T50.1 Loop [high-ceiling] diuretics
0.009 0.990 0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries
0.009 0.990 0.000
H17.9 Corneal scar and opacity, unspecified
0.000 0.991 0.009
H33 Retinal detachments and breaks
0.000 0.991 0.009
H50.6 Mechanical strabismus
0.000 0.991 0.009
H04.2 Epiphora
0.000 0.991 0.009
I63.3 Cerebral infarction due to thrombosis of cerebral arteries
0.009 0.991 0.000
H45 Disorders of vitreous body and globe in diseases classified elsewhere
0.000 0.991 0.009
I63.1 Cerebral infarction due to embolism of precerebral arteries
0.009 0.991 0.000
T50.7 Analeptics and opioid receptor antagonists
0.009 0.991 0.000
T50.5 Appetite depressants
0.009 0.991 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.009 0.991 0.000
T50.0 Mineralocorticoids and their antagonists
0.009 0.991 0.000
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
0.009 0.991 0.000
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
0.009 0.991 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.009 0.991 0.000
H04.4 Chronic inflammation of lachrymal passages
0.000 0.991 0.009
H16.2 Keratoconjunctivitis
0.000 0.991 0.009
H50.0 Convergent concomitant strabismus
0.000 0.991 0.009
H44.5 Degenerated conditions of globe
0.000 0.991 0.009
H34 Retinal vascular occlusions
0.000 0.991 0.009
H17.8 Other corneal scars and opacities
0.000 0.991 0.008
H30 Chorioretinal inflammation
0.000 0.991 0.009
H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere
0.000 0.991 0.008
H50.8 Other specified strabismus
0.000 0.991 0.008
H49 Paralytic strabismus
0.000 0.991 0.008
H50.9 Strabismus, unspecified
0.000 0.991 0.009
H31 Other disorders of choroid
0.000 0.991 0.008
H44.1 Other endophthalmitis
0.000 0.992 0.008
H32 Chorioretinal disorders in diseases classified elsewhere
0.000 0.992 0.008
H44.4 Hypotony of eye
0.000 0.992 0.008
H21.2 Degeneration of iris and ciliary body
0.000 0.992 0.008
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.008 0.992 0.000
T50.8 Diagnostic agents
0.008 0.992 0.000
T45.0 Antiallergic and antiemetic drugs
0.008 0.992 0.000
H16.3 Interstitial and deep keratitis
0.000 0.992 0.008
I63.8 Other cerebral infarction
0.008 0.992 0.000
H43.2 Crystalline deposits in vitreous body
0.000 0.992 0.008
H43.3 Other vitreous opacities
0.000 0.992 0.008
H33.5 Other retinal detachments
0.000 0.992 0.008
H04.9 Disorder of lachrymal system, unspecified
0.000 0.992 0.008
H44.9 Disorder of globe, unspecified
0.000 0.992 0.008
H44.8 Other disorders of globe
0.000 0.992 0.008
T50.4 Drugs affecting uric acid metabolism
0.008 0.992 0.000
H16.4 Corneal neovascularisation
0.000 0.992 0.008
H16.8 Other keratitis
0.000 0.992 0.008
H51.9 Disorder of binocular movement, unspecified
0.000 0.992 0.007
H51.8 Other specified disorders of binocular movement
0.000 0.992 0.007
H51.1 Convergence insufficiency and excess
0.000 0.992 0.007
H51.0 Palsy of conjugate gaze
0.000 0.992 0.007
H44.6 Retained (old) intraocular foreign body, magnetic
0.000 0.992 0.008
H44.3 Other degenerative disorders of globe
0.000 0.992 0.008
H31.0 Chorioretinal scars
0.000 0.992 0.008
H16.1 Other superficial keratitis without conjunctivitis
0.000 0.992 0.007
H43.0 Vitreous prolapse
0.000 0.993 0.007
H16.9 Keratitis, unspecified
0.000 0.993 0.007
H04.6 Other changes in lachrymal passages
0.000 0.993 0.007
H44.0 Purulent endophthalmitis
0.000 0.993 0.007
T45.5 Anticoagulants
0.007 0.993 0.000
H04.0 Dacryoadenitis
0.000 0.993 0.007
H34.2 Other retinal artery occlusions
0.000 0.993 0.007
T50.6 Antidotes and chelating agents, not elsewhere classified
0.007 0.993 0.000
H35 Other retinal disorders
0.000 0.993 0.007
H52.0 Hypermetropia
0.000 0.993 0.007
H35.4 Peripheral retinal degeneration
0.000 0.993 0.007
H26.2 Complicated cataract
0.000 0.993 0.007
H44.7 Retained (old) intraocular foreign body, nonmagnetic
0.000 0.993 0.007
T50.9 Other and unspecified drugs, medicaments and biological substances
0.007 0.993 0.000
H43.9 Disorder of vitreous body, unspecified
0.000 0.993 0.007
H35.0 Background retinopathy and retinal vascular changes
0.000 0.993 0.007
H52.2 Astigmatism
0.000 0.993 0.007
H30.2 Posterior cyclitis
0.000 0.993 0.007
H34.9 Retinal vascular occlusion, unspecified
0.000 0.993 0.007
N20.0 Calculus of kidney
0.007 0.993 0.000
H51.2 Internuclear ophthalmoplegia
0.000 0.993 0.007
H49.2 Sixth [abducent] nerve palsy
0.000 0.993 0.007
H40-H42 Glaucoma
0.000 0.993 0.007
H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere
0.000 0.993 0.007
H45.1 Endophthalmitis in diseases classified elsewhere
0.000 0.993 0.007
I63.0 Cerebral infarction due to thrombosis of precerebral arteries
0.006 0.993 0.000
H31.8 Other specified disorders of choroid
0.000 0.993 0.006
H34.0 Transient retinal artery occlusion
0.000 0.993 0.006
H30.8 Other chorioretinal inflammations
0.000 0.993 0.006
H30.1 Disseminated chorioretinal inflammation
0.000 0.993 0.006
H30.0 Focal chorioretinal inflammation
0.000 0.993 0.006
H48.8 Other disorders of optic nerve and visual pathways in diseases classified elsewhere
0.000 0.993 0.006
H48.1 Retrobulbar neuritis in diseases classified elsewhere
0.000 0.993 0.006
H48.0 Optic atrophy in diseases classified elsewhere
0.000 0.993 0.006
H49.3 Total (external) ophthalmoplegia
0.000 0.994 0.006
H30.9 Chorioretinal inflammation, unspecified
0.000 0.994 0.006
H31.4 Choroidal detachment
0.000 0.994 0.006
H31.2 Hereditary choroidal dystrophy
0.000 0.994 0.006
H34.8 Other retinal vascular occlusions
0.000 0.994 0.006
H49.8 Other paralytic strabismus
0.000 0.994 0.006
H04.3 Acute and unspecified inflammation of lachrymal passages
0.000 0.994 0.006
H35.7 Separation of retinal layers
0.000 0.994 0.006
E83.4 Disorders of magnesium metabolism
0.000 0.994 0.006
H45.0 Vitreous haemorrhage in diseases classified elsewhere
0.000 0.994 0.006
H31.9 Disorder of choroid, unspecified
0.000 0.994 0.006
H32.8 Other chorioretinal disorders in diseases classified elsewhere
0.000 0.994 0.006
H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere
0.000 0.994 0.006
H33.4 Traction detachment of retina
0.000 0.994 0.006
H00-H06 Disorders of eyelid, lacrimal system and orbit
0.000 0.994 0.006
H49.1 Fourth [trochlear] nerve palsy
0.000 0.994 0.006
H49.4 Progressive external ophthalmoplegia
0.000 0.994 0.006
H33.2 Serous retinal detachment
0.000 0.994 0.006
H04.8 Other disorders of lachrymal system
0.000 0.994 0.006
D23.6 Skin of upper limb, including shoulder
0.000 0.994 0.006
M19.04 Primary arthrosis of other joints (Hand)
0.000 0.994 0.006
H35.5 Hereditary retinal dystrophy
0.000 0.994 0.006
H31.1 Choroidal degeneration
0.000 0.994 0.006
H34.1 Central retinal artery occlusion
0.000 0.994 0.005
H35.1 Retinopathy of prematurity
0.000 0.994 0.005
H10-H13 Disorders of conjunctiva
0.000 0.995 0.005
H49.0 Third [oculomotor] nerve palsy
0.000 0.995 0.005
H36 Retinal disorders in diseases classified elsewhere
0.000 0.995 0.005
H33.0 Retinal detachment with retinal break
0.000 0.995 0.005
H31.3 Choroidal haemorrhage and rupture
0.000 0.995 0.005
H33.3 Retinal breaks without detachment
0.000 0.995 0.005
H42 Glaucoma in diseases classified elsewhere
0.000 0.995 0.005
H49.9 Paralytic strabismus, unspecified
0.000 0.995 0.005
H04.1 Other disorders of lachrymal gland
0.000 0.995 0.005
H16.0 Corneal ulcer
0.000 0.995 0.005
H43.1 Vitreous haemorrhage
0.000 0.995 0.005
R82.9 Other and unspecified abnormal finding in urine
0.000 0.995 0.005
H03 Disorders of eyelid in diseases classified elsewhere
0.000 0.995 0.005
H35.9 Retinal disorder, unspecified
0.000 0.995 0.005
M11.26 Other chondrocalcinosis (Lower leg)
0.005 0.995 0.000
H35.6 Retinal haemorrhage
0.000 0.995 0.005
I49.0 Ventricular fibrillation and flutter
0.005 0.995 0.000
H47 Other disorders of optic [2nd] nerve and visual pathways
0.000 0.995 0.004
H44.2 Degenerative myopia
0.000 0.996 0.004
H55-H59 Other disorders of eye and adnexa
0.000 0.996 0.004
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.004 0.996 0.000
N18.5 Chronic kidney disease, stage 5
0.000 0.996 0.004
H36.8 Other retinal disorders in diseases classified elsewhere
0.000 0.996 0.004
K14.0 Glossitis
0.000 0.996 0.004
H42.8 Glaucoma in other diseases classified elsewhere
0.000 0.996 0.004
H42.0 Glaucoma in endocrine, nutritional and metabolic diseases
0.000 0.996 0.004
H03.1 Involvement of eyelid in other infectious diseases classified elsewhere
0.000 0.996 0.004
Z86.3 Personal history of endocrine, nutritional and metabolic diseases
0.000 0.996 0.004
I95.1 Orthostatic hypotension
0.000 0.996 0.004
H13 Disorders of conjunctiva in diseases classified elsewhere
0.000 0.996 0.003
K11.5 Sialolithiasis
0.000 0.996 0.004
H03.8 Involvement of eyelid in other diseases classified elsewhere
0.000 0.996 0.004
H03.0 Parasitic infestation of eyelid in diseases classified elsewhere
0.000 0.996 0.004
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere
0.000 0.996 0.004
H35.2 Other proliferative retinopathy
0.000 0.996 0.003
H47.5 Disorders of other visual pathways
0.000 0.996 0.003
H47.7 Disorder of visual pathways, unspecified
0.000 0.996 0.003
H47.6 Disorders of visual cortex
0.000 0.996 0.003
H47.4 Disorders of optic chiasm
0.000 0.996 0.003
E83.3 Disorders of phosphorus metabolism
0.000 0.997 0.003
M50.2 Other cervical disk displacement
0.003 0.997 0.000
H58 Other disorders of eye and adnexa in diseases classified elsewhere
0.000 0.997 0.003
Z99.2 Dependence on renal dialysis
0.000 0.997 0.003
H53-H54 Visual disturbances and blindness
0.000 0.997 0.003
X62.9 Unspecified place
0.003 0.997 0.000
Z04.8 Examination and observation for other specified reasons
0.003 0.997 0.000
H10 Conjunctivitis
0.001 0.997 0.003
I63.9 Cerebral infarction, unspecified
0.003 0.997 0.000
H47.2 Optic atrophy
0.000 0.997 0.003
R82.7 Abnormal findings on microbiological examination of urine
0.000 0.997 0.003
H13.8 Other disorders of conjunctiva in diseases classified elsewhere
0.000 0.997 0.003
H13.2 Conjunctivitis in other diseases classified elsewhere
0.000 0.997 0.003
H13.0 Filarial infection of conjunctiva
0.000 0.997 0.003
R82 Other abnormal findings in urine
0.000 0.997 0.003
E83 Disorders of mineral metabolism
0.000 0.997 0.003
H13.1 Conjunctivitis in infectious and parasitic diseases classified elsewhere
0.000 0.997 0.003
H06.3 Other disorders of orbit in diseases classified elsewhere
0.000 0.997 0.003
H06.1 Parasitic infestation of orbit in diseases classified elsewhere
0.000 0.997 0.003
H06.0 Disorders of lachrymal system in diseases classified elsewhere
0.000 0.997 0.003
H74.3 Other acquired abnormalities of ear ossicles
0.003 0.997 0.000
K14.9 Disease of tongue, unspecified
0.000 0.997 0.003
H47.0 Disorders of optic nerve, not elsewhere classified
0.000 0.997 0.003
M11.2 Other chondrocalcinosis
0.003 0.997 0.000
K14 Diseases of tongue
0.000 0.997 0.003
H81.0 Meniere's disease
0.000 0.997 0.003
H13.3 Ocular pemphigoid
0.001 0.997 0.002
E61.1 Iron deficiency
0.000 0.997 0.003
H10.0 Mucopurulent conjunctivitis
0.001 0.997 0.002
H58.9 Other specified disorders of eye and adnexa in diseases classified elsewhere
0.000 0.997 0.002
H58.1 Visual disturbances in diseases classified elsewhere
0.000 0.997 0.002
H58.0 Anomalies of pupillary function in diseases classified elsewhere
0.000 0.997 0.002
H74.4 Polyp of middle ear
0.003 0.997 0.000
H58.8 Visual disturbances in diseases classified elsewhere
0.000 0.997 0.003
H55 Nystagmus and other irregular eye movements
0.000 0.997 0.003
G25.8 Other specified extrapyramidal and movement disorders
0.000 0.997 0.003
R82.5 Elevated urine levels of drugs, medicaments and biological substances
0.000 0.997 0.003
H47.3 Other disorders of optic disk
0.000 0.997 0.002
R23.8 Other and unspecified skin changes
0.003 0.997 0.000
H47.1 Papilloedema, unspecified
0.000 0.997 0.002
N20 Calculus of kidney and ureter
0.003 0.997 0.000
H10.2 Other acute conjunctivitis
0.001 0.997 0.002
K14.8 Other diseases of tongue
0.000 0.997 0.003
H10.3 Acute conjunctivitis, unspecified
0.001 0.997 0.002
K14.3 Hypertrophy of tongue papillae
0.000 0.997 0.003
H10.5 Blepharoconjunctivitis
0.001 0.997 0.002
H10.8 Other conjunctivitis
0.001 0.997 0.002
N20.1 Calculus of ureter
0.003 0.997 0.000
H10.1 Acute atopic conjunctivitis
0.001 0.997 0.002
H10.4 Chronic conjunctivitis
0.001 0.997 0.002
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source
0.000 0.998 0.002
R82.3 Haemoglobinuria
0.000 0.998 0.002
R82.2 Biliuria
0.000 0.998 0.002
R82.0 Chyluria
0.000 0.998 0.002
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.998 0.002
E83.8 Other disorders of mineral metabolism
0.000 0.998 0.002
E83.2 Disorders of zinc metabolism
0.000 0.998 0.002
E83.0 Disorders of copper metabolism
0.000 0.998 0.002
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.002 0.998 0.000
G25.9 Extrapyramidal and movement disorder, unspecified
0.000 0.998 0.002
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified
0.000 0.998 0.002
M11.27 Other chondrocalcinosis (Ankle and foot)
0.002 0.998 0.000
M11.21 Other chondrocalcinosis (Shoulder region)
0.002 0.998 0.000
M11.29 Other chondrocalcinosis (Site unspecified)
0.002 0.998 0.000
M11.28 Other chondrocalcinosis (Other)
0.002 0.998 0.000
M11.25 Other chondrocalcinosis (Pelvic region and thigh)
0.002 0.998 0.000
M11.24 Other chondrocalcinosis (Hand)
0.002 0.998 0.000
M11.23 Other chondrocalcinosis (Forearm)
0.002 0.998 0.000
M11.22 Other chondrocalcinosis (Upper arm)
0.002 0.998 0.000
M11.20 Other chondrocalcinosis (Multiple sites)
0.002 0.998 0.000
K14.5 Plicated tongue
0.000 0.998 0.002
K14.4 Atrophy of tongue papillae
0.000 0.998 0.002
R82.4 Acetonuria
0.000 0.998 0.002
K14.1 Geographic tongue
0.000 0.998 0.002
M21.16 Varus deformity, not elsewhere classified (Lower leg)
0.002 0.998 0.000
Z57.3 Occupational exposure to other air contaminants
0.002 0.998 0.000
H35.8 Other specified retinal disorders
0.000 0.998 0.002
H05 Disorders of orbit
0.000 0.998 0.002
R47.0 Dysphasia and aphasia
0.002 0.998 0.000
R82.1 Myoglobinuria
0.000 0.998 0.002
H35.3 Degeneration of macula and posterior pole
0.000 0.998 0.002
N18.0 End-stage renal disease
0.000 0.998 0.002
R16.0 Hepatomegaly, not elsewhere classified
0.002 0.998 0.000
U80.1 Methicillin resistant agent
0.002 0.998 0.000
E83.5 Disorders of calcium metabolism
0.000 0.998 0.002
K80-K87 Disorders of gallbladder, biliary tract and pancreas
0.002 0.998 0.000
K14.6 Glossodynia
0.000 0.998 0.002
K14.2 Median rhomboid glossitis
0.000 0.998 0.002
X62.8 Other specified place
0.002 0.998 0.000
Z93.2 Ileostomy status
0.002 0.998 0.000
U89.8 Agent resistant to other single specified antibiotic
0.000 0.998 0.002
N18.8 Other chronic renal failure
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.